Clinical Study
Is Metabolic Syndrome Truly a Risk Factor for Male Lower Urinary Tract Symptoms or Just an Epiphenomenon?
Table 1
Demographic parameters of patients according to the presence of metabolic syndrome.
| Continuous variables | Metabolic syndrome () | Nonmetabolic syndrome () | P |
| Age (years) | 59 ± 9 | 57 ± 9 | 0.02 | Body mass index (Kg/m2) | 30 ± 4 | 26 ± 4 | <0.001 | Prostate volume (cm3) | 31 ± 9 | 29 ± 8 | 0.01 | Total PSA | 1.69 ± 4.1 | 1.49 ± 4.0 | 0.30 | Total testosterone (ng/dL) | 486 ± 250 | 512 ± 251 | 0.26 | Free testosterone (ng/dL) | 90 ± 66 | 97 ± 67 | 0.25 | IPSS | 5 ± 7 | 7 ± 7 | 0.12 |
|
|
PSA: prostate specific antigen; IPSS: International Prostatic Symptoms Score. Data in bold font refers to P value <0.05.
|